Meet the team
Dr Chris Doherty, Managing Director, Alderley Park
Chris is leading the Alderley Park site regeneration project which included the site sale and stimulating new business ventures on the site. As Site Director of the Park, Chris is managing the further development of the bioscience campus.
Chris graduated as a Pharmacist completing a PhD in pharmaceutical technology and a MBA a few years later. Chris worked for Glaxo in Canada and the UK in Development and Operations roles before moving to Roche to be Head of Pharmacy R&D for the UK.
Chris has over 26 years of pharmaceutical research and development experience and has been associated with bringing a number of brands through to launch in several major pharmaceutical companies.
Nick Hynes, Head of Development
Nick leads the development team and is responsible for the delivery of the commercial, residential and amenity elements of Alderley Park.
Nick is a Chartered Surveyor who has been operating in the North West property market for over 40 years and as a result has built up considerable expertise in asset, development and investment management together with the refurbishment and regeneration of property.
Dr Neil Jones, Science Services Manager
Neil has overall responsibility for the development and delivery of scientific lab services across the Mereside campus, including in-suite capabilities, site-wide services and centralised research facilities. He also supports lab construction and setup projects for new and existing customers and leads on sales for small laboratory suites within the BioHub.
Before joining Alderley Park in November 2015, Neil was Laboratory Operations Manager at Liverpool University where he established open access research laboratories specialising in high throughput formulation, synthesis and characterisation. Prior to this he was Technology Manager at an optoelectronics incubation and research centre in St Asaph. His background is in analytical chemistry, and he holds MChem and PhD degrees from the University of Leeds.
Dr Juliana Maynard, HEAD of Imaging Services
Juliana is responsible for the operation of the imaging centre together with the implementation of the imaging strategy, portfolio management and project delivery of the imaging studies. She is actively working to develop partnerships and collaborations across the life sciences sector providing the imaging expertise to fully utilise the imaging capabilities within the Park.
Juliana has a wealth of multi-modality imaging experience and has worked in the pharmaceutical, academic and CRO space for over 15 years actively publishing over 30 papers across a wide range of disease areas.
Juliana graduated from the University of St Andrews with a BSc Hons. in Physiology and obtained her PhD in Neuroendocrinology from the University of Edinburgh.
Elaine Wilson, SCIENCE Sales MANAGER
Elaine joined the team last year and is delighted to be a part of the transformation and development of the Park. Her role is focused on developing the demand pipeline and prospecting for the available laboratory space we have in the Park. She works very closely with science services, project management, marketing, finance and legal to provide a seamless customer experience.
Elaine graduated with a degree in Civil Engineering and focussed her early career on becoming a Chartered Civil Engineer. Since then she has enjoyed a diverse career with roles in Engineering, Compliance, Projects and Outsourcing.
Ned Wakeman, Director, BioHub - INCUBATION
As Director of the Incubation Services, Ned is responsible for the strategic direction and leadership of the incubator. He leads the support and growth of early stage, fast growing life science companies including managing the creation of business cases to support their expansion.
With proven sector expertise and awareness of market dynamics, Ned has been involved in excess of $250m of equity fund raisings for North American and European companies, including Eyegate Pharma, EffRx and Artielle Immunotherapeutics. Prior to investment banking, Ned conducted primary research in neuropsychopharmacology, psychoneuroimmunology, and neuroscience at Yale Medical School and the University of Oxford.